A Simple and Sensitive LC–MS/MS Method for Determination of Dapagliflozin and Its Major Metabolite in Human Plasma
Journal of Chromatographic Science · 2025
DOI: 10.1093/chromsci/bmaf019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2025. Verfasst von Zhijun Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, No. 1076 Yuhua Road, Chenggong District, Kunming, Yunnan …. Hauptthemen laut MEDLINE: Glucosides, Tandem Mass Spectrometry, Benzhydryl Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Clinical Research Project of Shanghai Municipal Health Commission, Shanghai Yiyuanxinxing Youth Medical Talents Development Program, Healthcare Quality Continuous Improvement Project of Changzheng Hospital.
Abstract (Originalsprache)
Dapagliflozin (DAPA), an inhibitor of sodium-dependent glucose cotransporter-2, has been created to treat individuals with type 2 diabetes mellitus. A method was developed and validated using high-performance liquid chromatography coupled to tandem mass spectrometry to aid in studying the connection between clinical effectiveness and concentration of DAPA and its primary metabolite dapagliflozin 3-O-glucuronide (D3OG) in human plasma. The two analytes were separated using the Waters XSELECT HSS T3 (2.1 × 100 mm, 3.5 μm; Waters Co., Milford, USA) chromatographic column, with a mobile phase flow rate of 0.3 mL/min. The elution program was performed after protein precipitation with methanol, which only required a 5-min duration. The extraction recovery was from 99.8 to 109% for DAPA and from 101 to 103% for D3OG. Validation of the method for detecting DAPA within the range of 5–50 ng/mL and D3OG within the range of 50–500 ng/mL demonstrated satisfactory inter- and intra-day precision and accuracy. The method was successfully developed and validated, and it was used to measure the levels of DAPA and D3OG in plasma samples from patients with type 2 diabetes mellitus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Yunnan University of Traditional Chinese Medicine, No. 1076 Yuhua Road, Chenggong District, Kunming, Yunnan 650500, China.
- Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, No. 415 Fengyang Road, Huangpu District, Shanghai 200003, China.
- Department of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, No. 2800 Gongwei Road, Pudong New District, Shanghai 201399, China.
- College of Pharmacy, Shanghai University of Medicine & Health Sciences, No. 279 Zhouzhu Highway, Pudong New District, Shanghai 201318, China.
ORCID-Profile: Shouhong Gao, Deduo Xu
Förderung
- Clinical Research Project of Shanghai Municipal Health Commission
- Shanghai Yiyuanxinxing Youth Medical Talents Development Program
- Healthcare Quality Continuous Improvement Project of Changzheng Hospital
Zitieren
APA
Liu, Z., Liu, Y., Wang, Z., Lu, H., Zhu, X., Bao, Y., Cai, B., Gao, S., Tao, X., & Xu, D. (2025). A Simple and Sensitive LC–MS/MS Method for Determination of Dapagliflozin and Its Major Metabolite in Human Plasma. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmaf019
Vancouver
Liu Z, Liu Y, Wang Z, Lu H, Zhu X, Bao Y, et al. A Simple and Sensitive LC–MS/MS Method for Determination of Dapagliflozin and Its Major Metabolite in Human Plasma. Journal of Chromatographic Science. 2025. doi:10.1093/chromsci/bmaf019
BibTeX
@article{Liu2025,
author = {Liu, Zhijun and Liu, Yanru and Wang, Zhipeng and Lu, Huiping and Zhu, Xiujing and Bao, Yuxi and Cai, Bingyan and Gao, Shouhong and Tao, Xia and Xu, Deduo},
title = {A Simple and Sensitive LC–MS/MS Method for Determination of Dapagliflozin and Its Major Metabolite in Human Plasma},
journal = {Journal of Chromatographic Science},
year = {2025},
doi = {10.1093/chromsci/bmaf019}
}
EUVIMED